Aerosol-Processed Thermosensitive Nanocomposites for Controlled Drug Release

-isopropylacrylamide (NIPAM)-polydimethylsiloxane (PDMS). The Fe nanoparticles reacted with NIPAM-PDMS in the atomized droplets to form encapsulated Fe nanoparticles, i.e., Fe@NIPAM-PDMS nanocomposites, whose size distribution was unimodal (showing only a NIPAM-PDMS-like distribution, with the Fe distribution eliminated). By varying processing temperatures, it was possible to obtain Fe@NIPAM-PDMS nanocomposites with different sizes and morphologies. This is further attributed to the quantitative incorporation of Fe nanoparticles into atomized NIPAM-PDMS-doxorubicin (DOX) droplets. The Fe@NIPAM-PDMS-DOX nanocomposites released different amounts of DOX under a magnetothermal effect, which produced different levels of cytotoxic effects on the targeted HeLa cells. The thermosensitivity makes these nanocomposites an ideal candidate for important applications such as controlled drug delivery.